News Medical

Researchers focus on the identification of markers to improve head and neck cancer risk assessment

Malignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic markers is a significant impediment to personalized treatment.
ascopubs.org

When Is Telemedicine Appropriate in the Management of Head and Neck Cancer? A Mixed-Methods Assessment Among Patients and Physicians

We performed a mixed-methods study at a multisite cancer center. First, we surveyed patients with HNC and analyzed factors that may influence their telemedicine experience using multivariate ...

Droplet Biosciences-Study Reveals Post-Surgical Lymph Fluid as a Powerful Source of ctDNA for Early Recurrence Detection in Head & Neck Cancer

Link to the article in Clinical Cancer Research.] The study utilized Droplet's LymphDetect (TM) liquid biopsy assay for HPV-independent head & neck cancer. Results from two cohorts (initial n = 36, ...
MedPage Today

Mixed Message for Ultrasound in High-Risk Cutaneous Head and Neck Cancer

Ultrasound outperformed baseline clinical assessment for detection of lymph node metastasis in patients with high-risk cutaneous squamous cell carcinoma (SCC) of the head and neck, a retrospective ...

Decoding that pain in the neck

Learn about neck pain causes, evaluation, management, and prevention strategies to maintain a healthy neck in the digital age ...
Business Wire

Castle Biosciences Presents New Data Demonstrating DecisionDx®-SCC Complements Current Risk Assessment Methods in Patients with Cutaneous Squamous Cell Carcinoma of the Head ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a dermatologic diagnostics company providing personalized genomic information to inform treatment decisions, today ...

Strong link between type 2 diabetes and hearing loss revealed

As the United States observes American Diabetes Month this November, a comprehensive study published in Otolaryngology–Head ...